Literature DB >> 8863677

Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats.

E S Yi1, H Lee, Y K Suh, W Tang, M Qi, S Yin, D G Remick, T R Ulich.   

Abstract

Extrinsic allergic alveolitis and pulmonary sarcoidosis are granulomatous diseases of the lung for which clinical presentation and anatomic site of granuloma formation differ. Extrinsic allergic alveolitis is caused by inhaled antigens, whereas the nature and source of the inciting antigen in sarcoidosis is unknown. To test the hypothesis that the route via which antigen is introduced to the lung contributes to the clinicopathological presentation of pulmonary granulomatous disease, rats immunized with intravenous (i.v.) Corynebacterium parvum were challenged after 2 weeks with either intratracheal (i.t.) or i.v. C. parvum. The granulomatous inflammation elicited by i.t. challenge predominantly involved alveolar spaces and histologically simulated extrinsic allergic alveolitis. In contrast, the inflammation induced by i.v. challenge was characterized by granulomatous angiitis and interstitial inflammation simulating sarcoidosis. Elevations of leukocyte counts and TNF levels in bronchoalveolar fluid, which reflect inflammation in the intra-alveolar compartment, were much more pronounced after i.t. than after i.v. challenge. Tumor necrosis factor, interleukin-6, CC chemokine, CXC chemokine, and adhesion molecule mRNA and protein expression occurred in each model. In conclusion, i.t. or i.v. challenge with C. parvum in sensitized rats caused pulmonary granulomatous inflammation that was histologically similar to human extrinsic allergic alveolitis and sarcoidosis, respectively. Although the soluble and cellular mediators of granulomatous inflammation were qualitatively similar in both disease models, the differing anatomic source of the same antigenic challenge was responsible for differing clinicopathological presentations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863677      PMCID: PMC1865196     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6.

Authors:  T R Ulich; K Z Guo; D Remick; J del Castillo; S M Yin
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

2.  Vascular lesions in the biopsied bronchus of patients with sarcoidosis changes of the endothelial cells in aggregation of eosinophils.

Authors:  I Mochizuki; T Kobayashi; R Wada; T Kawaguchi; K Ozawa; M Fukushima; Y Hirose; H Kono; J Takeda; S Kusama
Journal:  Sarcoidosis       Date:  1990-03

3.  The pathology of the acute and chronic stages of farmer's lung.

Authors:  R M Seal; E J Hapke; G O Thomas; J C Meek; M Hayes
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

4.  Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.

Authors:  J Y Tso; X H Sun; T H Kao; K S Reece; R Wu
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

5.  A macrophage LPS-inducible early gene encodes the murine homologue of IP-10.

Authors:  Y Ohmori; T A Hamilton
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

6.  Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines.

Authors:  T Yoshimura; M Takeya; K Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1991-01-31       Impact factor: 3.575

7.  Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor.

Authors:  S W Chensue; K Warmington; J Ruth; P Lincoln; M C Kuo; S L Kunkel
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 8.  The alveolitis of hypersensitivity pneumonitis.

Authors:  U Costabel
Journal:  Eur Respir J       Date:  1988-01       Impact factor: 16.671

9.  The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.

Authors:  G Kaplan; A D Luster; G Hancock; Z A Cohn
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties.

Authors:  G Davatelis; P Tekamp-Olson; S D Wolpe; K Hermsen; C Luedke; C Gallegos; D Coit; J Merryweather; A Cerami
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  4 in total

1.  Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice.

Authors:  Joshua G McCaskill; Kelly D Chason; Xiaoyang Hua; Isabel P Neuringer; Andrew J Ghio; William K Funkhouser; Stephen L Tilley
Journal:  Am J Respir Cell Mol Biol       Date:  2006-04-27       Impact factor: 6.914

2.  Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.

Authors:  Yoshinobu Eishi; Moritaka Suga; Ikuo Ishige; Daisuke Kobayashi; Tetsuo Yamada; Tamiko Takemura; Touichiro Takizawa; Morio Koike; Shoji Kudoh; Ulrich Costabel; Josune Guzman; Gianfranco Rizzato; Marcello Gambacorta; Ronald du Bois; Andrew G Nicholson; Om P Sharma; Masayuki Ando
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

3.  Real-time quantitative reverse transcription-polymerase chain reaction to detect propionibacterial ribosomal RNA in the lymph nodes of Chinese patients with sarcoidosis.

Authors:  Y Zhou; Y-R Wei; Y Zhang; S-S Du; R P Baughman; H-P Li
Journal:  Clin Exp Immunol       Date:  2015-07-01       Impact factor: 4.330

4.  Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes.

Authors:  Yoshinobu Eishi
Journal:  Biomed Res Int       Date:  2013-06-16       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.